Thus, synuclein-γ (SNCG) abnormal expression has been described in a wide range of human cancer such as endometrial [28], bladder [29], prostate [30], ovarian [31], gastric [32], liver [33], lung [34], colon [35], and breast [5, 6]. The gene discussed is SNCG; the disease is cancer.